These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9874055)

  • 1. Does withdrawal of antihypertensive medication increase the risk of cardiovascular events? Trial of Nonpharmacologic Interventions in the Elderly (TONE) Cooperative Research Group.
    Kostis JB; Espeland MA; Appel L; Johnson KC; Pierce J; Wofford JL
    Am J Cardiol; 1998 Dec; 82(12):1501-8. PubMed ID: 9874055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors and mediators of successful long-term withdrawal from antihypertensive medications. TONE Cooperative Research Group. Trial of Nonpharmacologic Interventions in the Elderly.
    Espeland MA; Whelton PK; Kostis JB; Bahnson JL; Ettinger WH; Cutler JA; Appel LJ; Kumanyika S; Farmer D; Elam J; Wilson AC; Applegate WB
    Arch Fam Med; 1999; 8(3):228-36. PubMed ID: 10333818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group.
    Whelton PK; Appel LJ; Espeland MA; Applegate WB; Ettinger WH; Kostis JB; Kumanyika S; Lacy CR; Johnson KC; Folmar S; Cutler JA
    JAMA; 1998 Mar; 279(11):839-46. PubMed ID: 9515998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial.
    Appel LJ; Espeland M; Whelton PK; Dolecek T; Kumanyika S; Applegate WB; Ettinger WH; Kostis JB; Wilson AC; Lacy C
    Ann Epidemiol; 1995 Mar; 5(2):119-29. PubMed ID: 7795830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications.
    Ayala DE; Hermida RC; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):340-52. PubMed ID: 23077973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Antihypertensive Deprescribing Strategies on Blood Pressure, Adverse Events, and Orthostatic Symptoms in Older Adults: Results From TONE.
    Juraschek SP; Cluett JL; Belanger MJ; Anderson TS; Ishak A; Sahni S; Millar C; Appel LJ; Miller ER; Lipsitz LA; Mukamal KJ
    Am J Hypertens; 2022 Apr; 35(4):337-346. PubMed ID: 34718403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term predictors of maintenance of normotension after withdrawal of antihypertensive drugs in the second Australian National Blood Pressure Study (ANBP2).
    Nelson MR; Reid CM; Krum H; Ryan P; Wing LM; McNeil JJ;
    Am J Hypertens; 2003 Jan; 16(1):39-45. PubMed ID: 12517681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association Between Antihypertensive Medication Nonadherence and Visit-to-Visit Variability of Blood Pressure: Findings From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Kronish IM; Lynch AI; Oparil S; Whittle J; Davis BR; Simpson LM; Krousel-Wood M; Cushman WC; Chang TI; Muntner P
    Hypertension; 2016 Jul; 68(1):39-45. PubMed ID: 27217410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
    Curb JD; Pressel SL; Cutler JA; Savage PJ; Applegate WB; Black H; Camel G; Davis BR; Frost PH; Gonzalez N; Guthrie G; Oberman A; Rutan GH; Stamler J
    JAMA; 1996 Dec; 276(23):1886-92. PubMed ID: 8968014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of discontinuation of antihypertensive medication on orthostatic hypotension in older persons with mild cognitive impairment: the DANTE Study Leiden.
    Moonen JE; Foster-Dingley JC; de Ruijter W; van der Grond J; de Craen AJ; van der Mast RC
    Age Ageing; 2016 Mar; 45(2):249-55. PubMed ID: 26758532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
    Hermida RC; Ayala DE; Fernández JR; Mojón A
    Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE).
    Appel LJ; Espeland MA; Easter L; Wilson AC; Folmar S; Lacy CR
    Arch Intern Med; 2001 Mar; 161(5):685-93. PubMed ID: 11231700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: further analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial.
    Davis BR; Cutler JA; Furberg CD; Wright JT; Farber MA; Felicetta JV; Stokes JD;
    Ann Intern Med; 2002 Sep; 137(5 Part 1):313-20. PubMed ID: 12204014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
    Leenen FH
    Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
    Thomas GN; Chan P; Tomlinson B
    Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
    Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incremental effects of antihypertensive drugs: instrumental variable analysis.
    Markovitz AA; Mack JA; Nallamothu BK; Ayanian JZ; Ryan AM
    BMJ; 2017 Dec; 359():j5542. PubMed ID: 29273586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withdrawal of antihypertensive therapy in the elderly. The issues.
    Fotherby MD
    Drugs Aging; 1995 Jun; 6(6):436-44. PubMed ID: 7663063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks.
    Hermida RC; Ayala DE; Smolensky MH; Fernández JR; Mojón A; Portaluppi F
    Hypertens Res; 2016 May; 39(5):277-92. PubMed ID: 26657008
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.